189 related articles for article (PubMed ID: 25347735)
1. Oncogenic Ras inhibits IRF1 to promote viral oncolysis.
Komatsu Y; Christian SL; Ho N; Pongnopparat T; Licursi M; Hirasawa K
Oncogene; 2015 Jul; 34(30):3985-93. PubMed ID: 25347735
[TBL] [Abstract][Full Text] [Related]
2. IRF1 Downregulation by Ras/MEK Is Independent of Translational Control of IRF1 mRNA.
Komatsu Y; Derwish L; Hirasawa K
PLoS One; 2016; 11(8):e0160529. PubMed ID: 27508303
[TBL] [Abstract][Full Text] [Related]
3. Restoration of IRF1-dependent anticancer effects by MEK inhibition in human cancer cells.
AbuSara N; Razavi S; Derwish L; Komatsu Y; Licursi M; Hirasawa K
Cancer Lett; 2015 Feb; 357(2):575-81. PubMed ID: 25497010
[TBL] [Abstract][Full Text] [Related]
4. Suppression of IFN-induced transcription underlies IFN defects generated by activated Ras/MEK in human cancer cells.
Christian SL; Zu D; Licursi M; Komatsu Y; Pongnopparat T; Codner DA; Hirasawa K
PLoS One; 2012; 7(9):e44267. PubMed ID: 22970192
[TBL] [Abstract][Full Text] [Related]
5. Activated Ras/MEK inhibits the antiviral response of alpha interferon by reducing STAT2 levels.
Christian SL; Collier TW; Zu D; Licursi M; Hough CM; Hirasawa K
J Virol; 2009 Jul; 83(13):6717-26. PubMed ID: 19386709
[TBL] [Abstract][Full Text] [Related]
6. The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells.
Noser JA; Mael AA; Sakuma R; Ohmine S; Marcato P; Lee PW; Ikeda Y
Mol Ther; 2007 Aug; 15(8):1531-6. PubMed ID: 17505473
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway.
Battcock SM; Collier TW; Zu D; Hirasawa K
J Virol; 2006 May; 80(9):4422-30. PubMed ID: 16611902
[TBL] [Abstract][Full Text] [Related]
8. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.
Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M
J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245
[TBL] [Abstract][Full Text] [Related]
9. Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling.
Malilas W; Koh SS; Srisuttee R; Boonying W; Cho IR; Jeong CS; Johnston RN; Chung YH
Cancer Gene Ther; 2013 Feb; 20(2):125-32. PubMed ID: 23306614
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic reovirus induces intracellular redistribution of Ras to promote apoptosis and progeny virus release.
Garant KA; Shmulevitz M; Pan L; Daigle RM; Ahn DG; Gujar SA; Lee PW
Oncogene; 2016 Feb; 35(6):771-82. PubMed ID: 25961930
[TBL] [Abstract][Full Text] [Related]
11. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program.
Negishi H; Fujita Y; Yanai H; Sakaguchi S; Ouyang X; Shinohara M; Takayanagi H; Ohba Y; Taniguchi T; Honda K
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15136-41. PubMed ID: 17018642
[TBL] [Abstract][Full Text] [Related]
12. Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.
Yu N; Puckett S; Antinozzi PA; Cramer SD; Lyles DS
J Virol; 2015 May; 89(10):5250-63. PubMed ID: 25741004
[TBL] [Abstract][Full Text] [Related]
13. Global gene analysis identifying genes commonly regulated by the Ras/Raf/MEK and type I IFN pathways.
Komatsu Y; Hirasawa K; Christian SL
Genom Data; 2015 Jun; 4():84-7. PubMed ID: 26484185
[TBL] [Abstract][Full Text] [Related]
14. Uterine Leiomyosarcoma Tumorigenesis in Lmp2-deficient Mice: Involvement of Impaired Anti-oncogenic Factor IRF1.
Hayashi T; Horiuchi A; Sano K; Yaegashi N; Konishi I
Anticancer Res; 2015 Sep; 35(9):4665-79. PubMed ID: 26254356
[TBL] [Abstract][Full Text] [Related]
15. Suppression of IRF4 by IRF1, 3, and 7 in Noxa expression is a necessary event for IFN-γ-mediated tumor elimination.
Piya S; Moon AR; Song PI; Hiscott J; Lin R; Seol DW; Kim TH
Mol Cancer Res; 2011 Oct; 9(10):1356-65. PubMed ID: 21816905
[TBL] [Abstract][Full Text] [Related]
16. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
17. IRF1 Maintains Optimal Constitutive Expression of Antiviral Genes and Regulates the Early Antiviral Response.
Panda D; Gjinaj E; Bachu M; Squire E; Novatt H; Ozato K; Rabin RL
Front Immunol; 2019; 10():1019. PubMed ID: 31156620
[TBL] [Abstract][Full Text] [Related]
18. Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release.
Marcato P; Shmulevitz M; Pan D; Stoltz D; Lee PW
Mol Ther; 2007 Aug; 15(8):1522-30. PubMed ID: 17457318
[TBL] [Abstract][Full Text] [Related]
19. Tumors driven by RAS signaling harbor a natural vulnerability to oncolytic virus M1.
Cai J; Lin K; Cai W; Lin Y; Liu X; Guo L; Zhang J; Xu W; Lin Z; Wong CW; Sander M; Hu J; Yan G; Zhu W; Liang J
Mol Oncol; 2020 Dec; 14(12):3153-3168. PubMed ID: 33037696
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells.
Ryu SH; Kim KH; Kim HB; Kim MH; Kim NH; Kang Y; Hyun JW; Seo HJ; Jun JY; You HJ
Cancer Sci; 2010 Sep; 101(9):1990-6. PubMed ID: 20550525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
